Twitter   LinkedInFacebookRSS  
Press Releases

Certara Adds Four Global Leaders to its Simcyp® PBPK, QSP and QSTS Modeling and Simulation Division

PRINCETON, NJ - Apr 17, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced four senior executive appointments in its Simcyp division

WCG Expands its Research Site Executive Team, Global Research Network

PRINCETON, NJ - Apr 12, 2019 - The WIRB-Copernicus Group® (WCG™) is pleased to announce the addition of several prominent executives to its Site Division and the expansion of its Global Research Network™ (GRN) of investigative sites

WCG Announces the Acquisition of Analgesic Solutions, LLC

PRINCETON, NJ - Apr 4, 2019 - The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announces the acquisition of Analgesic Solutions, LLC, the global leader in the development of new pain medications and in the support of clinical trials in which pain is an indicator of an underlying condition

BINDING SITE OFFERS NATIVE BORDETELLA PERTUSSIS ANTIGENS

SAN DIEGO, CA - Apr 3, 2019 - ~~BINDING SITE’s IMMUNOLOGICALS GROUP is pleased to announce the addition of three (3) new native Bordetella pertussis antigens to its broad offering of products for in-vitro diagnostic (IVD) manufacturing and research applications

OncoCell Announces Late-Breaking Poster Presentation at AACR 2019 on a Noninvasive Blood-Based Assay for Prostate Cancer Prognosis

ATLANTA, GA, UNITED STATES - Apr 1, 2019 - April 1, 2019 - ATLANTA - OncoCell MDx, a company developing novel noninvasive diagnostic and prognostic tests, will present results from a feasibility study of a new prostate cancer prognostic assay in a late-breaking poster session at the American Association of Cancer Research (AACR) Annual Meeting tomorrow

BioIVT Joins the Foundation for the National Institutes of Health Biomarkers Consortium

WESTBURY, NY - Mar 25, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has joined the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium

WCG Introduces a Transformational Solution for Clinical Research Sites

PRINCETON, NJ - Mar 19, 2019 - WIRB-Copernicus Group® (WCG™) introduces WCG SiteReady™, a first-of-its-kind solution aimed at increasing the efficiency and profitability of clinical research for institutions and independent research sites

BioIVT Webinar to Discuss Ethical and Regulatory Issues Regarding Use of Human Biospecimens in Life Sciences Research in the UK and EU

WESTBURY, NY - Mar 18, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will be co-hosting a one-hour webinar entitled “Gaining Clarity: Unique Considerations for the Ethical and Regulatory Use of Human Biospecimens in the European Union (EU) and United Kingdom (UK)” at 8 a

Precision BioLogic’s CRYOcheck™ Factor VIII Inhibitor Kit Cleared for Sale in U.S.

HALIFAX, NS, CANADA - Mar 13, 2019 - Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce FDA 510(k) clearance and the launch of its CRYOcheck Factor VIII Inhibitor Kit in the U

Certara Scientists Advance ASCPT Agenda: From Molecule to Patient

PRINCETON, NJ - Mar 13, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that its pharmacokinetic/pharmacodynamic (PK/PD), quantitative systems pharmacology (QSP) and physiologically-based pharmacokinetic (PBPK) modeling experts will participate in 21 sessions at the American Society for Clinical Pharmacology & Therapeutics (ASCPT) 2019 Annual Meeting

Cadex Genomics Announces Pivotal Cancer Therapy Non-Response Monitoring Study with Rocky Mountain Cancer Centers

REDWOOD CITY, CA, UNITED STATES - Mar 12, 2019 - Cadex Genomics, Corp. announced that it has initiated a pivotal clinical study designed to validate the ability of Alibrex to act as a biomarker for predicting early non-response to therapy in stage IV cancer patients

Rehabilitation Technology Expert Signs Letter of Intent to Employ Shimmer’s Verisense™ Continuous Monitoring Platform in New Clinical Trial

CAMBRIDGE, MA - Mar 11, 2019 - Shimmer, a global leader in wearable technology for research applications, announced that Paolo Bonato, PhD, director of the Motion Analysis Laboratory at Spaulding Rehabilitation Hospital in Boston, has signed a letter of intent to employ Shimmer’s Verisense continuous monitoring platform during his next clinical trial to study motor recovery in stroke survivors

New TB blood test enters clinical trials

LEICESTER, UK - Mar 6, 2019 - A new blood test for tuberculosis (TB) could, for the first time, enable screening of patients at an early stage of infection

BioIVT Launches Its XPRESSWAY® Profile Safety Package, a Gene Expression Reference Guide Designed to Improve Drug Safety Analyses

WESTBURY, NY - Mar 6, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the launch of its XPRESSWAY Profile Safety Package, a compendium of 46 gene expression profiles for genes known to play pivotal roles in drug safety assessments

Menarini Silicon Biosystems Develops New Assay Workflow for Circulating Multiple Myeloma Cells

HUNTINGDON VALLEY, PA, UNITED STATES - Mar 5, 2019 -   Menarini Silicon Biosystems, the pioneer of liquid biopsy technology, announced today that it will introduce a new semi-automated assay workflow utilizing the CELLSEARCH® and DEPArrayTM platforms to enumerate and characterize circulating multiple myeloma cells (CMMC) from peripheral blood samples

Centers for Disease Control and Prevention (CDC) Selects Certara to Develop Technology Platform to Strengthen the Agency’s Death Investigation and Surveillance Systems

PRINCETON, NJ - Mar 5, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that the US Centers for Disease Control & Prevention (CDC) has awarded it a contract to strengthen the Agency’s death investigation and surveillance systems

MR Solutions’ high-field multi-modality, cryogen-free MRI system on display at EMIM

GUILDFORD, UNITED KINGDOM - Feb 27, 2019 - MR Solutions’ latest compact preclinical, multi-modality MRI systems will be on display at the 14th European Molecular Imaging Meeting (EMIM 2019) being held at the Scottish Event Campus in Glasgow on 19 to 22 March, 2019

AlloSure now available for Lung Transplant Patients

LOS ANGELES, CA, UNITED STATES - Feb 21, 2019 - https://globenewswire.com/news-release/2019/02/21/1739290/0/en/AlloSure-now-available-for-Lung-Transplant-Patients

Certara Launches Version 19.1 of its D360 Scientific Informatics Platform

PRINCETON, NJ - Feb 21, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the launch of version 19

SAW Diagnostics Receives £1.5M Innovate UK Funding to Support Commercialisation of its Point of Care Diagnostics Technology Platform

GLASGOW, UK - Feb 12, 2019 - SAW Diagnostics Limited (SAW Dx), an emerging biological sample analysis and point of care diagnostic company, announced today that Innovate UK, the UK’s innovation Agency, has awarded the company a £1
 1